XML 26 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Unaudited Condensed Interim Consolidated Statements of Shareholders’ Equity - USD ($)
Share capital
Fair value of RSUs issued at $1.84 per share
Share capital
Fair value of RSUs issued at $1.11 per share
Share capital
Restricted stock units at 0.97 per share [Member]
Share capital
Restricted stock units at 0.83 per share [Member]
Share capital
Restricted stock units at 0.71 per share [Member]
Share capital
Restricted stock units at 0.26 per share [Member]
Share capital
Restricted stock units at 0.23 per share [Member]
Share capital
Contributed surplus
Fair value of RSUs issued at $1.84 per share
Contributed surplus
Fair value of RSUs issued at $1.11 per share
Contributed surplus
Other reserves
Fair value of RSUs issued at $1.84 per share
Other reserves
Fair value of RSUs issued at $1.11 per share
Other reserves
Restricted stock units at 0.97 per share [Member]
Other reserves
Restricted stock units at 0.83 per share [Member]
Other reserves
Restricted stock units at 0.71 per share [Member]
Other reserves
Restricted stock units at 0.26 per share [Member]
Other reserves
Restricted stock units at 0.23 per share [Member]
Other reserves
Accumulated deficit
Fair value of RSUs issued at $1.84 per share
Accumulated deficit
Fair value of RSUs issued at $1.11 per share
Accumulated deficit
Restricted stock units at 0.97 per share [Member]
Accumulated deficit
Restricted stock units at 0.83 per share [Member]
Accumulated deficit
Restricted stock units at 0.71 per share [Member]
Accumulated deficit
Restricted stock units at 0.26 per share [Member]
Accumulated deficit
Restricted stock units at 0.23 per share [Member]
Accumulated deficit
Accumulated other comprehensive loss
Fair value of RSUs issued at $1.84 per share
Accumulated other comprehensive loss
Fair value of RSUs issued at $1.11 per share
Accumulated other comprehensive loss
Restricted stock units at 0.97 per share [Member]
Accumulated other comprehensive loss
Restricted stock units at 0.83 per share [Member]
Accumulated other comprehensive loss
Restricted stock units at 0.71 per share [Member]
Accumulated other comprehensive loss
Restricted stock units at 0.26 per share [Member]
Accumulated other comprehensive loss
Restricted stock units at 0.23 per share [Member]
Accumulated other comprehensive loss
Fair value of RSUs issued at $1.84 per share
Fair value of RSUs issued at $1.11 per share
Restricted stock units at 0.97 per share [Member]
Restricted stock units at 0.83 per share [Member]
Restricted stock units at 0.71 per share [Member]
Restricted stock units at 0.26 per share [Member]
Restricted stock units at 0.23 per share [Member]
Total
Balance at Dec. 31, 2018               $ 10                                   $ (1,467,480)                             $ (1,467,470)
Effective of change in par value               (7)                     7                                          
Share issuance               156                                                               156
Net loss                                                 (1,394,641)                             (1,394,641)
Translation adjustment                                                               (42,566)               (42,566)
Balance at Dec. 31, 2019               159                     7               (2,862,121)               (42,566)               (2,904,521)
Share issuance               1,477                                                               1,477
Contribution to reserves by owners of the Company                                   21,046                                           21,046
Net loss                                                 (2,300,571)                             (2,300,571)
Translation adjustment                                                               150,626               150,626
Balance (Previously stated) at Dec. 31, 2020               159                     21,053               (5,162,692)               108,060               (5,031,943)
Balance at Dec. 31, 2020               1,636                     21,053               (5,162,692)               108,060               (5,031,943)
Fair value of RSU’s issued                                                                                    
Net loss | Previously stated                                                 (8,131,197)                             (8,131,197)
Net loss                                                 (8,131,197)                             (8,131,197)
Translation adjustment | Previously stated                                                               110,042               110,042
Translation adjustment                                                               110,042               110,042
Balance (Previously stated) at Dec. 31, 2021               7,255,695                   3,618,670               (13,293,889)               218,102               (2,201,422)
Balance at Dec. 31, 2021                                                                                     7,255,695
Recapitalization | Previously stated                                   3,597,617                                           35,977
Recapitalization                                   3,597,617                                           3,597,617
Issuance of shares for cash, net of costs | Previously stated               5,054,059                                                               5,054,059
Issuance of shares for cash, net of costs               5,054,059                                                               5,054,059
Shares for debt | Previously stated               2,200,000                                                               2,200,000
Shares for debt               2,200,000                                                               2,200,000
Issuance of shares for Holigen Acquisition | Previously stated               16,131,000                                                             16,131,000
Issuance of shares to ASDT | Previously stated               2,174,908                                                             2,174,908
Issuance of shares from private placement | Previously stated               298,684                                                             298,684
Issuance of shares from IPO | Previously stated               14,682,078                                                             14,682,078
Issuance of shares upon conversion of note | Previously stated               6,559,000                                                             6,559,000
Loss of control of Bophelo Bio | Previously stated               (156)                   (3,597,619)               3,863,601               (232,712)               33,114
Stock-based compensation | Previously stated                   576,340                                                         576,340
Net loss | Previously stated                                               (2,593,744)                             (2,593,744)
Net loss                                                                                     (2,593,744)
Translation adjustment | Previously stated                                                             (1,019,498)               (1,019,498)
Translation adjustment                                                                                     (1,019,498)
Balance (Previously stated) at Jun. 30, 2022               47,101,209     576,340               21,051               (12,024,032)               (1,034,108)               34,640,460
Balance (Previously stated) at Dec. 31, 2021               7,255,695                   3,618,670               (13,293,889)               218,102               (2,201,422)
Balance at Dec. 31, 2021                                                                                     7,255,695
Issuance of shares for Holigen Acquisition               16,131,000                                                               16,131,000
Issuance of shares to ASDT               2,124,615                                                               2,124,615
Issuance of shares from private placement               278,481                                                               278,481
Issuance of shares from IPO               14,654,593                                                               14,654,593
Issuance of shares upon conversion of note               6,559,000                                                               6,559,000
Loss of control of Bophelo Bio               (156)                     (3,597,617)               3,863,601               (290,216)               (24,388)
Fair value of RSU’s issued     $ 1,090,832 $ 560,135 $ 431,757 $ 210,740 $ 138,000                               $ 1,090,832 $ 560,135 $ 431,757 $ 210,740 $ 138,000 2,498,754
Net loss                                                 (11,657,674)                               (11,657,674)
Translation adjustment                                                               (1,395,508)               (1,395,508)
Balance (Previously stated) at Dec. 31, 2022               49,434,692                   21,053               (21,087,962)               (1,467,622)               26,900,161
Balance at Dec. 31, 2022                                                                                     49,434,692
Fair value of RSU’s issued | Previously stated $ 774,736 $ 179,037                                                   $ 774,736 $ 179,037            
Cancelled shares | Previously stated               (200,014)                                                             (200,014)
Net loss | Previously stated                                               (5,877,882)                             (5,877,882)
Net loss                                                                                     (5,877,882)
Translation adjustment | Previously stated                                                             (126,995)               (126,995)
Translation adjustment                                                                                     (126,995)
Balance (Previously stated) at Jun. 30, 2023               $ 50,188,451                   $ 21,053               $ (26,965,844)               $ (1,594,617)               $ 21,649,043